APA (7th ed.) Citation

Bensch, F., Veen, E. L. v. d., Hooge, M. N. L., Jorritsma-Smit, A., Boellaard, R., Kok, I. C., . . . Vries, E. G. E. d. (2018). 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nature medicine, 24(12), 1852-1858. https://doi.org/10.1038/s41591-018-0255-8

Chicago Style (17th ed.) Citation

Bensch, Frederike, et al. "89Zr-atezolizumab Imaging as a Non-invasive Approach to Assess Clinical Response to PD-L1 Blockade in Cancer." Nature Medicine 24, no. 12 (2018): 1852-1858. https://doi.org/10.1038/s41591-018-0255-8.

MLA (9th ed.) Citation

Bensch, Frederike, et al. "89Zr-atezolizumab Imaging as a Non-invasive Approach to Assess Clinical Response to PD-L1 Blockade in Cancer." Nature Medicine, vol. 24, no. 12, 2018, pp. 1852-1858, https://doi.org/10.1038/s41591-018-0255-8.